MEDIROM Healthcare Technologies(MRM)
$0.28+0.02 (+5.75%)
MRM
MEDIROM Healthcare Technologies financials statements
$0.28
At close:+0.02 (+5.75%)
Want to see MRM full AI Analyst Report?
MEDIROM Healthcare Technologies (MRM) Ratios
131 Followers
MEDIROM Healthcare Technologies Ratios
MRM's free cash flow for Q2 2024 was ¥-804.41M. For the 2024 fiscal year, MRM's free cash flow was decreased by ¥-18.70M and operating cash flow was ¥-831.32M. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.65 | 0.49 | 0.65 | 0.43 | 0.79 |
| Quick Ratio | 0.61 | 0.45 | 0.62 | 0.43 | 0.78 |
| Cash Ratio | 0.08 | 0.03 | 0.17 | 0.12 | 0.54 |
| Solvency Ratio | 0.06 | 0.06 | 0.05 | -0.15 | -0.09 |
| Operating Cash Flow Ratio | -0.32 | -0.18 | -0.19 | -0.17 | -0.14 |
| Short-Term Operating Cash Flow Coverage | -1.20 | -1.26 | -6.91 | -3.43 | -1.51 |
| Net Current Asset Value | ¥ -4.20B | ¥ -4.87B | ¥ -4.44B | ¥ -4.58B | ¥ -3.13B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.49 | 0.53 | 0.48 | 0.49 | 0.45 |
| Debt-to-Equity Ratio | 4.24 | 17.31 | -54.42 | -13.40 | 5.21 |
| Debt-to-Capital Ratio | 0.81 | 0.95 | 1.02 | 1.08 | 0.84 |
| Long-Term Debt-to-Capital Ratio | 0.45 | 0.83 | 1.05 | 1.39 | 0.58 |
| Financial Leverage Ratio | 8.67 | 32.48 | -113.63 | -27.61 | 11.63 |
| Debt Service Coverage Ratio | 0.41 | 0.75 | 3.15 | -4.89 | -1.81 |
| Interest Coverage Ratio | -0.36 | -10.62 | 9.89 | -39.38 | -56.38 |
| Debt to Market Cap | 2.27 | 0.37 | 0.39 | 0.27 | 0.15 |
| Interest Debt Per Share | 784.49 | 713.57 | 592.46 | 575.06 | 639.85 |
| Net Debt to EBITDA | 9.36 | 11.43 | 7.03 | -8.77 | -2.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 27.07% | 22.98% | 27.36% | 26.16% | 12.84% |
| EBIT Margin | 1.17% | 0.84% | 2.73% | -7.44% | -18.36% |
| EBITDA Margin | 4.67% | 4.54% | 5.37% | -5.11% | -16.49% |
| Operating Profit Margin | -0.22% | -5.73% | 1.39% | -8.70% | -22.33% |
| Pretax Profit Margin | 0.57% | 0.30% | 2.59% | -7.66% | -18.75% |
| Net Profit Margin | 1.79% | 1.68% | 2.14% | -18.31% | -16.14% |
| Continuous Operations Profit Margin | 1.67% | 1.68% | 2.14% | -18.31% | -16.14% |
| Net Income Per EBT | 311.79% | 557.89% | 82.86% | 239.03% | 86.03% |
| EBT Per EBIT | -263.58% | -5.27% | 185.40% | 88.08% | 84.00% |
| Return on Assets (ROA) | 1.84% | 1.68% | 2.21% | -17.22% | -9.44% |
| Return on Equity (ROE) | 15.94% | 54.56% | -250.88% | 475.53% | -109.75% |
| Return on Capital Employed (ROCE) | -0.46% | -11.91% | 3.12% | -18.41% | -24.37% |
| Return on Invested Capital (ROIC) | -0.31% | -8.60% | 2.02% | -13.55% | -16.20% |
| Return on Tangible Assets | 2.27% | 2.11% | 2.57% | -20.81% | -9.87% |
| Earnings Yield | 17.98% | 2.76% | 4.61% | -29.16% | -9.01% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.15 | 5.56 | 13.01 | 17.32 | 22.50 |
| Payables Turnover | 5.97 | 38.19 | 24.34 | 17.30 | 43.46 |
| Inventory Turnover | 39.92 | 37.57 | 44.27 | 213.57 | 366.10 |
| Fixed Asset Turnover | 3.31 | 2.69 | 2.92 | 2.41 | 1.84 |
| Asset Turnover | 1.03 | 1.00 | 1.03 | 0.94 | 0.58 |
| Working Capital Turnover Ratio | -5.06 | -4.43 | -4.50 | -4.55 | -4.61 |
| Cash Conversion Cycle | 36.02 | 65.80 | 21.31 | 1.68 | 8.82 |
| Days of Sales Outstanding | 88.04 | 65.64 | 28.06 | 21.07 | 16.22 |
| Days of Inventory Outstanding | 9.14 | 9.72 | 8.24 | 1.71 | 1.00 |
| Days of Payables Outstanding | 61.16 | 9.56 | 15.00 | 21.10 | 8.40 |
| Operating Cycle | 97.18 | 75.36 | 36.31 | 22.78 | 17.22 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -260.74 | -122.29 | -125.34 | -114.25 | -91.05 |
| Free Cash Flow Per Share | -371.32 | -148.59 | -147.41 | -133.86 | -109.32 |
| Dividend Paid and CapEx Coverage Ratio | -2.36 | -4.65 | -5.68 | -5.83 | -4.98 |
| Capital Expenditure Coverage Ratio | -2.36 | -4.65 | -5.68 | -5.83 | -4.98 |
| Operating Cash Flow Coverage Ratio | -0.34 | -0.17 | -0.21 | -0.20 | -0.14 |
| Operating Cash Flow to Sales Ratio | -0.16 | -0.09 | -0.10 | -0.10 | -0.11 |
| Free Cash Flow Yield | -229.17% | -18.43% | -24.93% | -19.22% | -7.35% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 5.56 | 36.20 | 21.71 | -3.43 | -11.10 |
| Price-to-Sales (P/S) Ratio | 0.10 | 0.61 | 0.47 | 0.63 | 1.79 |
| Price-to-Book (P/B) Ratio | 0.89 | 19.75 | -54.48 | -16.31 | 12.18 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.44 | -5.43 | -4.01 | -5.20 | -13.60 |
| Price-to-Operating Cash Flow Ratio | -0.62 | -6.59 | -4.72 | -6.10 | -16.33 |
| Price-to-Earnings Growth (PEG) Ratio | 0.24 | -1.60 | -0.19 | -0.07 | 0.00 |
| Enterprise Value Multiple | 11.50 | 24.86 | 15.69 | -21.06 | -12.89 |
| Enterprise Value | 4.46B | 7.71B | 5.86B | 5.82B | 7.11B |
| EV to EBITDA | 11.50 | 24.86 | 15.69 | -21.06 | -12.89 |
| EV to Sales | 0.54 | 1.13 | 0.84 | 1.08 | 2.13 |
| EV to Free Cash Flow | -2.35 | -10.04 | -7.27 | -8.91 | -16.15 |
| EV to Operating Cash Flow | -3.35 | -12.20 | -8.55 | -10.44 | -19.39 |
| Tangible Book Value Per Share | -66.64 | -230.23 | -183.26 | -245.98 | 60.36 |
| Shareholders’ Equity Per Share | 182.73 | 40.82 | -10.85 | -42.72 | 122.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -1.90 | -4.58 | 0.17 | -1.39 | 0.14 |
| Revenue Per Share | 1624.92 | 1321.76 | 1271.16 | 1109.18 | 830.31 |
| Net Income Per Share | 29.13 | 22.27 | 27.23 | -203.13 | -133.97 |
| Tax Burden | 3.12 | 5.58 | 0.83 | 2.39 | 0.86 |
| Interest Burden | 0.49 | 0.36 | 0.95 | 1.03 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.27 | 0.26 | 0.24 | 0.31 | 0.29 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 |
| Income Quality | -9.64 | -5.49 | -4.60 | 0.56 | 0.68 |
Currency in JPY
